BioPorto Announces Interim Results for the First Six Months of 2023 August 1, 2023Announcement no. 14...…
BioPorto A/S to Host Second Quarter 2023 Earnings Webcast and Analyst Call July 7, 2023News Release...…
BioPorto Announces Submission of Response to FDA Additional Information Letter June 29, 2023News release...…
BioPorto A/S announces completion of rights issue; total number of shares and voting rights June 23, 2023Announcement no. 12...…
HC Andersen Capital Events 12/6: Meet the top management in BioPorto & Shape Robotics HC Andersen Capital is hosting digital events where you can meet and ask questions directly to the top management. It…
BioPorto A/S to Webcast with HCA and Nordnet regarding the ongoing rights issue June 9, 2023News release...…
BioPorto A/S initiates a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4 million with approximately DKK 16.6 million pre-subscribed pursuant to advance commitments May 30, 2023Announcement no. 10...…
BioPorto Announces Interim Results for the First Three Months of 2023 May 10, 2023Announcement no. 8...…
HC Andersen Capital Events 10/05: Meet the top management in BioPorto HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management.…
BioPorto Announces Annual Results for the Year ended December 31, 2022 March 30, 2023Announcement no. 4...…
HC Andersen Capital Events 30/03: Meet the top management in Penneo, Impero, MapsPeople, Ascelia Pharma, Roblon & BioPorto HC Andersen Capital is hosting digital events where you can meet and ask questions directly to the top management. It…
Renal Biomarkers Technologies and Global Report 2022: Market Data and Projections 2019-2027 Featuring BioMerieux, Gentian Diagnostic, Proteomics, Thermo Fisher Scientific, SphingoTec, and BioPorto DUBLIN, Jan. 4, 2023 /PRNewswire/ -- The "Renal Biomarkers: Technologies and Global Markets" report has been added to ResearchAndMarkets.coms offering.…